Illumina INC:1107104 [17-034174]
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700386P
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $26,358
Award facts
- Opportunity
-
- N02RC7257936A Solicitation number
- Determination of DNA methylation status for 70 small cell lung cancer panel of cell lines using the Illumina 850K DNA methylation array Award Notice · Posted May 11, 2017
- Contract value 100% obligated
- $26,357.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Illumina, Inc. for $26,357.76 on June 29, 2017, with an ultimate completion date of June 30, 2018. Work is performed in San Diego, California. The order covers sequencing reagents, consumables, or related biotechnology products and services. No set-aside category applied to this procurement.
Quick answers
Who was awarded contract HHSN261201700386P?
HHSN261201700386P was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on June 29, 2017.
How much is contract HHSN261201700386P worth?
The government has obligated $26,358 on HHSN261201700386P.
Was contract HHSN261201700386P competed?
The extent of competition for HHSN261201700386P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award